Page 1 | Search Results | Archives of Pathology & Laboratory Medicine

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern

Marjorie Perron, MD, PhD, Hannah Y. Wen, MD, PhD, Matthew G. Hanna, MD, Edi Brogi, MD, PhD, Dara S. Ross, MD

Arch Pathol Lab Med (2020) 145 (8): 979–987.

https://doi.org/10.5858/arpa.2020-0288-OA

Published: 19 November 2020

View articletitled, HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern

Journal Articles

Triple-Positive Breast Carcinoma: Histopathologic Features and Response to Neoadjuvant Chemotherapy

Jennifer Zeng, MD, Marcia Edelweiss, MD, Dara S. Ross, MD, Bin Xu, MD, Tracy-Ann Moo, MD ...

Arch Pathol Lab Med (2020) 145 (6): 728–735.

https://doi.org/10.5858/arpa.2020-0293-OA

Published: 28 October 2020

View articletitled, Triple-Positive Breast Carcinoma: Histopathologic Features and Response to Neoadjuvant Chemotherapy

Journal Articles

Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With HER2 /CEP17 Ratio <2.0 and Average HER2 Copy Number ≥4.0 and <6.0

Raza S. Hoda, MD, Edi Brogi, MD, PhD, Jin Xu, MD, Katia Ventura, MS, Dara S. Ross, MD ...

Arch Pathol Lab Med (2019) 144 (5): 597–601.

https://doi.org/10.5858/arpa.2019-0307-OA

Published: 24 October 2019

View articletitled, Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With HER2 /CEP17 Ratio <2.0 and Average HER2 Copy Number ≥4.0 and <6.0